
Shishir Kumar Maithel MD
Hepatobiliary Surgery, Pancreas, Surgical Oncology (Other than Breast), Minimally Invasive Surgery
Professor of Surgery, Emory University School of Medicine
Join to View Full Profile
101 W Ponce de Leon AveDecatur, GA 30030
Phone+1 404-778-5014
Fax+1 404-778-4490
Dr. Maithel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Beth Israel Deaconess Medical CenterResidency, Surgery, 2000 - 2007
- University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2000
Certifications & Licensure
- GA State Medical License 2009 - 2026
- IL State Medical License 2024 - 2026
- NY State Medical License 2006 - 2010
- MA State Medical License 2003 - 2007
- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Gemcitabine/Cisplatin for Resected Pancreas Cancer: Establishing the Role of ERCC1 in Treatment Decision Start of enrollment: 2010 Jul 01
- Chemotherapy Before & After Surgery in Patients With Resectable Gallbladder Cancer Start of enrollment: 2019 Apr 03
- Gemcitabine, Cisplatin, and Nab-Paclitaxel Before Surgery in Patients With High-Risk Liver Bile Duct Cancer Start of enrollment: 2018 Sep 26
- Join now to see all
Publications & Presentations
PubMed
- Impact of intraoperative blood loss on postoperative morbidity after liver resection for primary and secondary liver cancer.Abdullah Altaf, Miho Akabane, Mujtaba Khalil, Zayed Rashid, Shahzaib Zindani
HPB. 2025-05-01 - 1 citations"Biological R2" resection for intrahepatic cholangiocarcinoma: identification of patients at risk for poor oncologic outcomes after curative-intent resection.Jun Kawashima, Yutaka Endo, Selamawit Woldesenbet, Mujtaba Khalil, Miho Akabane
HPB. 2025-05-01 - ASO Visual Abstract: The Composite Endpoint of Liver Surgery CELS-Development and Validation of a Clinically Relevant Endpoint Requiring Lower Sample Size.Jun Kawashima, Miho Akabane, Yutaka Endo, Selamawit Woldesenbet, Mujtaba Khalil
Annals of Surgical Oncology. 2025-05-01
Journal Articles
- Very Early Recurrence After Liver Resection for Intrahepatic CholangiocarcinomaDiamantis I Tsilimigras, Todd W Bauer, George A Poultsides, Shishir K Maithel, Kazunari Sasaki, Federico Aucejo, Timothy M Pawlik, JAMA Surgery
- Prognostic Role of Lymph Node Positivity and Number of Lymph Nodes Needed for Accurately Staging Small Bowel Neuroendocrine TumorsFlavio Rocha, Eleftherios Makris, Mary Dillhoff, Hari Nathan, Daniel Abbott, Shishir K Maithel, Mohammad Y Zaidi, Kenneth Cardona, Megan Beems, Kamran Idrees, JAMA
- Surgery Provides Long-Term Survival in Patients with Metastatic Neuroendocrine Tumors Undergoing Resection for Non-Hormonal SymptomsFlavio G Rocha, Zaheer Kanji, Carl R Schmidt, Mary Dillhoff, Megan Beems, Eleftherios Makris, Sharon Weber, Kamran Idrees, Shishir K Maithel, Jeffery Chakedis, Timothy..., Journal of gastrointestinal surgery
- Join now to see all
Authored Content
- Very Early Recurrence After Liver Resection for Intrahepatic CholangiocarcinomaJuly 2020
- Very Early Recurrence After Liver Resection for Intrahepatic CholangiocarcinomaJuly 2020
- Database Differences and LimitationsNovember 2018
Press Mentions
- Second Resections in Gallbladder Cancer Tied to Better OS, but Barely UsedMay 24th, 2021
- Hepatocellular Carcinoma, Novel Therapies on the HorizonJuly 22nd, 2021
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: